{"id":787,"date":"2026-09-18T09:00:00","date_gmt":"2026-09-18T09:00:00","guid":{"rendered":"https:\/\/ipglobalguard.com\/patent-strategy-tech-startups\/"},"modified":"2026-09-18T09:00:00","modified_gmt":"2026-09-18T09:00:00","slug":"patent-strategy-tech-startups","status":"publish","type":"post","link":"https:\/\/ipglobalguard.com\/en\/blog\/patent-strategy-tech-startups\/","title":{"rendered":"Patent strategy for tech startups: patent, utility model or trade secret?"},"content":{"rendered":"<p>A sound patent strategy for tech startups and SaaS SMEs starts by deciding what to protect, and how, before deciding where. In Europe, software is patentable only where it makes a technical contribution, so the usual answer is a mix: patents for the technical core that competitors can see or copy, trade secrets for back-end know-how they cannot observe, and utility models only for physical products. The first filing normally goes to your home office, and the PCT then gives you up to 30 or 31 months to choose markets. This guide is for founders and in-house teams in Europe, Latin America and Africa planning their first filings.<\/p>\n<blockquote><p><strong>Update (October 2026):<\/strong> WIPO&#8217;s PCT Newsletter 09\/2026 (SME Support Series No. 4) has since added a method for choosing national phase countries: ask first whether exclusivity is commercially necessary in each market, then score the options on weighted criteria such as full-life cost, quality and enforceability of protection and expected return, updating the file around month 26 and circulating a recommendation around month 28. <a href=\"https:\/\/www.wipo.int\/documents\/d\/pct-system\/newsletters-en-2026-pct-news-2026-9.pdf\" target=\"_blank\" rel=\"noopener\">WIPO, PCT Newsletter 09\/2026<\/a>.<\/p><\/blockquote>\n<h2>Key takeaways<\/h2>\n<ul>\n<li>Programs for computers are excluded from patentability in Europe only &#8220;as such&#8221;: software that solves a technical problem can be patented.<\/li>\n<li>A trade secret lasts as long as it stays secret and is protected only if you take <strong>reasonable steps<\/strong> to keep it so; reverse engineering and independent discovery are lawful.<\/li>\n<li>In Spain, utility models cannot protect processes, which rules them out for most software and SaaS methods.<\/li>\n<li>European and PCT applications for an invention made in Spain must go through the Spanish office (OEPM) unless they claim an earlier Spanish priority.<\/li>\n<li>Used as a business calendar, the PCT defers most costs to month 30 or 31 while you test the market and raise funds.<\/li>\n<\/ul>\n<h2>Can you patent software or a SaaS platform in Europe?<\/h2>\n<p>Yes, within limits. <a href=\"https:\/\/www.epo.org\/en\/legal\/epc\/2020\/a52.html\" target=\"_blank\" rel=\"noopener\">Article 52 of the European Patent Convention<\/a> (EPC) lists &#8220;programs for computers&#8221; and &#8220;methods for doing business&#8221; among things that are not inventions, but paragraph 3 limits the exclusion to such subject matter &#8220;as such&#8221;. The <a href=\"https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2015-8328\" target=\"_blank\" rel=\"noopener\">Spanish Patents Act 24\/2015<\/a> (Article 4.4) follows the same model. In EPO practice, computer-implemented inventions are typically patentable when they produce a technical effect, such as faster or more secure data processing, better use of hardware, signal or image processing or the control of a device. A pricing rule or a business workflow coded in software, without a technical effect, will not pass.<\/p>\n<p>The practical consequence for a SaaS company is that the patentable part is rarely &#8220;the platform&#8221;. It is a specific technical mechanism inside it, described with enough detail that a skilled engineer could reproduce it.<\/p>\n<h2>Patent, utility model or trade secret: which fits a tech SME?<\/h2>\n<table>\n<thead>\n<tr>\n<th>Tool<\/th>\n<th>What it protects<\/th>\n<th>Duration<\/th>\n<th>Disclosure<\/th>\n<th>Main limitation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Patent<\/td>\n<td>Products and processes, including computer-implemented inventions with a technical effect<\/td>\n<td>20 years from filing (Spanish Act, Art. 58)<\/td>\n<td>Published, normally 18 months after priority<\/td>\n<td>Cost, examination, absolute novelty<\/td>\n<\/tr>\n<tr>\n<td>Utility model (Spain)<\/td>\n<td>Configuration, structure or composition of an object or product<\/td>\n<td>10 years from filing (Art. 148)<\/td>\n<td>Published<\/td>\n<td>Excludes processes, biological material and pharmaceuticals (Art. 137)<\/td>\n<\/tr>\n<tr>\n<td>Trade secret<\/td>\n<td>Any technical or business information with value because it is secret<\/td>\n<td>As long as it stays secret<\/td>\n<td>None<\/td>\n<td>Lost if leaked; no protection against independent discovery or reverse engineering<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Under Spain&#8217;s <a href=\"https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2019-2364\" target=\"_blank\" rel=\"noopener\">Trade Secrets Act 1\/2019<\/a>, which transposes Directive (EU) 2016\/943, information qualifies as a trade secret only if it is secret, has business value because it is secret and has been subject to reasonable measures to keep it secret (Article 1). Article 2 makes acquisition lawful by independent discovery or by observing, studying, dismantling or testing a product lawfully available.<\/p>\n<h2>How do you decide what to patent and what to keep secret?<\/h2>\n<p>A simple test works for most SaaS and deep-tech companies: can you detect and prove that a competitor is using it?<\/p>\n<ul>\n<li><strong>Patent it<\/strong> if the feature is visible in the product, the interface, a device, a communication protocol or a standard, or if a competitor could copy it from your public documentation.<\/li>\n<li><strong>Keep it secret<\/strong> if it runs on your servers, cannot be observed from outside and would be hard to reverse engineer: training data pipelines, internal optimisation, parameter choices.<\/li>\n<li><strong>Consider both<\/strong> for a platform: patent the technical interface or method that defines the market, and keep the implementation details as know-how.<\/li>\n<li><strong>Remember investors<\/strong>: a filed application is an asset that can be listed in due diligence; a trade secret needs documented confidentiality measures to count.<\/li>\n<\/ul>\n<p>Our recommendation: run this triage invention by invention, with the technical lead and the commercial owner together, before anything is shown publicly.<\/p>\n<h2>Where should a tech SME file first?<\/h2>\n<p>The first filing sets the priority date, and from it the 12-month Paris priority year and the PCT calendar run. The common options:<\/p>\n<ul>\n<li><strong>National office first<\/strong> (for example the OEPM in Spain). For inventions made in Spain, Articles 152.2 and 163.2 of the Spanish Patents Act require European and PCT applications to be filed through the OEPM unless they claim an earlier Spanish priority; if the applicant is based in Spain, the invention is presumed to have been made there.<\/li>\n<li><strong>European application first<\/strong> at the EPO, when Europe is the main market. In its December 2025 notice on accelerated prosecution, the <a href=\"https:\/\/www.epo.org\/en\/legal\/official-journal\/2025\/12\/a69\" target=\"_blank\" rel=\"noopener\">EPO<\/a> reported a mean of five and a half months in 2024 to issue the extended European search report, which gives an early view of patentability inside the priority year.<\/li>\n<li><strong>PCT application first<\/strong>, when markets are still open and you want a single filing covering all PCT states from day one.<\/li>\n<\/ul>\n<p>For a Latin American or African company the logic is the same: file at home, then use the priority year to prepare a PCT application that keeps Europe and the rest of the corridor open.<\/p>\n<h2>How to use the 30-month PCT calendar as a business tool<\/h2>\n<p>WIPO&#8217;s <a href=\"https:\/\/www.wipo.int\/documents\/d\/pct-system\/newsletters-en-2026-pct-news-2026-6.pdf\" target=\"_blank\" rel=\"noopener\">PCT Newsletter 06\/2026<\/a> (SME Support Series No. 3) describes the PCT timeline as a business planning tool as well as a legal one. Months run from the priority date:<\/p>\n<table>\n<thead>\n<tr>\n<th>Month<\/th>\n<th>PCT step<\/th>\n<th>Business decision<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Before filing<\/td>\n<td>None yet<\/td>\n<td>NDAs, ownership by founders, staff and contractors, patent vs secret triage<\/td>\n<\/tr>\n<tr>\n<td>0\u201312<\/td>\n<td>First filing; PCT application within 12 months to claim priority<\/td>\n<td>Test the business case, markets, competitors and budget<\/td>\n<\/tr>\n<tr>\n<td>Around 16<\/td>\n<td>International search report and written opinion<\/td>\n<td>Refine claims, reassess risk, update investor materials<\/td>\n<\/tr>\n<tr>\n<td>18<\/td>\n<td>International publication<\/td>\n<td>Last point to withdraw and keep the invention unpublished<\/td>\n<\/tr>\n<tr>\n<td>22 (or 3 months from the search report)<\/td>\n<td>Optional demand for preliminary examination (Chapter II)<\/td>\n<td>Decide whether a positive report would help before national phase<\/td>\n<\/tr>\n<tr>\n<td>30 or 31<\/td>\n<td>National and regional phase entries<\/td>\n<td>Choose countries; this is where most costs arise<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>WIPO&#8217;s <a href=\"https:\/\/www.wipo.int\/en\/web\/pct-system\/texts\/time_limits\" target=\"_blank\" rel=\"noopener\">table of time limits<\/a> shows, for example, 30 months for Brazil and Mexico and 31 months for Colombia and for the EPO. Entries do not have to happen on the same day, and early entry is possible where a fast grant matters.<\/p>\n<h2>What this means for your business<\/h2>\n<ol>\n<li>List inventions, not products: one platform may contain two patentable mechanisms and several trade secrets.<\/li>\n<li>Put confidentiality in place before any pitch, demo or open-source release: NDAs, access controls, a register of what is secret.<\/li>\n<li>Confirm that founders, employees and contractors have assigned their rights to the company.<\/li>\n<li>File first where the law and your market point, then diary the 12-month priority deadline and the PCT milestones.<\/li>\n<li>Well before month 30, prepare the country decision with sales, finance and the technical lead.<\/li>\n<\/ol>\n<p>If you want this mapped for your own technology, our <a href=\"https:\/\/ipglobalguard.com\/en\/services\/patents\/\">patent strategy and PCT filing team<\/a> can run the triage and plan filings across Europe, Latin America and Africa.<\/p>\n<h2>Where tech startups get patent strategy wrong<\/h2>\n<ul>\n<li><strong>Disclosing before filing.<\/strong> Under <a href=\"https:\/\/www.epo.org\/en\/legal\/epc\/2020\/a54.html\" target=\"_blank\" rel=\"noopener\">Article 54 EPC<\/a>, anything made available to the public before filing is prior art, including your own pitch deck or conference talk. Article 55 only excuses evident abuse and certain international exhibitions.<\/li>\n<li>Claiming the business idea instead of the technical solution, which leads to refusal at the EPO.<\/li>\n<li>Calling something a trade secret without the measures that make it one.<\/li>\n<li>Filing abroad first from Spain, which can leave the patent without effect in Spain.<\/li>\n<li>Leaving software and AI assets outside the plan; our <a href=\"https:\/\/ipglobalguard.com\/en\/services\/ai-digital-assets\/\">AI and digital assets team<\/a> covers code, models and data alongside patents.<\/li>\n<\/ul>\n<h2>Frequently asked questions<\/h2>\n<h3>Can a SaaS company patent its software in Europe?<\/h3>\n<p>It can patent a computer-implemented invention that solves a technical problem with technical means, such as more efficient data processing or secure communication. Article 52 EPC excludes computer programs only &#8220;as such&#8221;, so a business method or pricing logic simply coded in software is not patentable on its own.<\/p>\n<h3>Is a trade secret better than a patent for a startup?<\/h3>\n<p>It depends on visibility. A secret suits back-end processes competitors cannot observe and has no time limit, but it disappears if leaked and does not stop independent development or reverse engineering. A patent suits features that can be seen or copied from the product.<\/p>\n<h3>Where should a Spanish startup file its first patent application?<\/h3>\n<p>If the invention was made in Spain, the European or PCT application must be filed through the OEPM unless it claims an earlier Spanish priority; otherwise the patent may have no effect in Spain. Many startups file a Spanish application first and use the priority year to prepare the PCT.<\/p>\n<h3>Can IP Global Guard build a patent strategy for our tech company?<\/h3>\n<p>Yes. We run the patent, utility model and trade secret triage, prepare and coordinate the first filing and the PCT application, and plan national phase entries with European patent attorneys and local correspondents across Europe, Latin America and Africa, from a single point of contact.<\/p>\n<h2>How IP Global Guard can help your tech company<\/h2>\n<p>For a young tech company, patent strategy is mostly sequence: protect the right thing, in the right form, before it goes public, and spend on countries only when the business case is clear. IP Global Guard, the IP services line of META Channel Corporation Limited, coordinates that sequence across our <a href=\"https:\/\/ipglobalguard.com\/en\/coverage\/\">25+ jurisdictions in Europe, Latin America and Africa<\/a>, with one strategy and one billing relationship.<\/p>\n<p>Tell us what your technology does, what is already public and which markets you are targeting in the next three years. We will propose what to patent, what to keep secret and where to file first. <a href=\"https:\/\/ipglobalguard.com\/en\/contact\/\">Talk to our patent strategy team<\/a>.<\/p>\n<p><em>This article is general information, not legal advice, and does not replace an assessment of your specific technology.<\/em><\/p>\n<h2>Sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.epo.org\/en\/legal\/epc\/2020\/a52.html\" target=\"_blank\" rel=\"noopener\">EPO, European Patent Convention, Article 52 (patentable inventions)<\/a><\/li>\n<li><a href=\"https:\/\/www.epo.org\/en\/legal\/epc\/2020\/a54.html\" target=\"_blank\" rel=\"noopener\">EPO, European Patent Convention, Article 54 (novelty)<\/a><\/li>\n<li><a href=\"https:\/\/www.epo.org\/en\/legal\/epc\/2020\/a55.html\" target=\"_blank\" rel=\"noopener\">EPO, European Patent Convention, Article 55 (non-prejudicial disclosures)<\/a><\/li>\n<li><a href=\"https:\/\/www.epo.org\/en\/legal\/official-journal\/2025\/12\/a69\" target=\"_blank\" rel=\"noopener\">EPO, OJ EPO 2025, A69, notice on the PACE programme (16 December 2025)<\/a><\/li>\n<li><a href=\"https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2015-8328\" target=\"_blank\" rel=\"noopener\">BOE, Spanish Patents Act 24\/2015 (consolidated text)<\/a><\/li>\n<li><a href=\"https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2019-2364\" target=\"_blank\" rel=\"noopener\">BOE, Trade Secrets Act 1\/2019 (consolidated text)<\/a><\/li>\n<li><a href=\"https:\/\/www.wipo.int\/documents\/d\/pct-system\/newsletters-en-2026-pct-news-2026-6.pdf\" target=\"_blank\" rel=\"noopener\">WIPO, PCT Newsletter No. 06\/2026, SME Support Series No. 3 (June 2026)<\/a><\/li>\n<li><a href=\"https:\/\/www.wipo.int\/en\/web\/pct-system\/texts\/time_limits\" target=\"_blank\" rel=\"noopener\">WIPO, Time limits for entering the national\/regional phase under the PCT<\/a><\/li>\n<li><a href=\"https:\/\/www.wipo.int\/documents\/d\/pct-system\/newsletters-en-2026-pct-news-2026-9.pdf\" target=\"_blank\" rel=\"noopener\">WIPO, PCT Newsletter No. 09\/2026, SME Support Series No. 4 (September 2026; update block only)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>What to patent, what to keep secret and where to file first: a decision framework for tech and SaaS SMEs, using the 30-month PCT calendar as a business tool.<\/p>\n","protected":false},"author":1,"featured_media":1377,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wds_primary_category":0,"footnotes":""},"categories":[28],"tags":[70,74,78,44,66,58],"class_list":["post-787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patents","tag-epo","tag-pct","tag-smes","tag-spain","tag-trade-secrets","tag-wipo"],"_links":{"self":[{"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/posts\/787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/comments?post=787"}],"version-history":[{"count":0,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/posts\/787\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/media\/1377"}],"wp:attachment":[{"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/media?parent=787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/categories?post=787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipglobalguard.com\/en\/wp-json\/wp\/v2\/tags?post=787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}